Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

European vaccine manufacturing is being boosted with high level investments.  

Booster Shot for Pharma

There are many promising trials in the pipeline that may bring big news for major therapeutic areas.

Clinical Trials and their Impact on the Pharma Industry

Mike Hennessy Jr. is the Chairman and CEO of 

Pharma's ability to continually reinvent itself will be critical in growing future business operations.

Billions of Reasons to be Buoyant

Interpreting data and understanding the various components of biologic 
drug substance testing is an important skillset to know as a lab personnel.


Data Integrity's Impact in Drug Substance Testing

Feliza Mirasol is the science editor for 

Bristol Myers Squibb has joined Cellares’ Technology Adoption Partnership program just as Cellares launches operations as an integrated development and manufacturing organization.

Bristol Myers Squibb Joins Cellares Program Focused on Automated Cell Therapy Manufacturing as Cellares is Launched as First IDMO

The Centers for Medicare & Medicaid Services (CMS) has announced the first 10 drugs covered under Medicare Part D selected for negotiation. 

White House Sets Medicare Price Negotiation Targets

Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) is approved as a first-line treatment for anemia in adults with lower-risk myelodysplastic syndromes.

FDA Approves Bristol Myers Squibb Anemia Treatment

The updated vaccine will be ready to ship following a positive European Commission review. 

Pfizer and BioNTech Get Positive Opinion in Europe for Omicron XBB.1.5-adapted COVID-19 Vaccine

Twist Bioscience is a synthetic biology and genomics company that has developed a DNA synthesis platform to industrialize the engineering of biology, which is a new method of this process by “writing” DNA on a silicon chip.

Ono Pharmaceutical Enters Drug Discovery Collaboration Agreement with Twist Bioscience

The new products aim to aid consumers with menopause and eye health-related issues.

News